CRP and COVID-19: Studies have concluded that in critically ill COVID-19 patients, CRP and PCT have shown rebound increases upon cessation of immunomodulator treatment, and as such, clinicians should assess basic clinical infection signs and cultures for diagnosis of secondary bacterial infections.3,75